CIK 0001728117 · Non-accelerated filer<br>Smaller reporting company
Gossamer Bio, Inc.
Sign in to watch- Ticker
- GOSS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475461709
- Phone
- (858) 684-1300
- Business address
- 3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 1,908 shares at $0.66 ($1,260)
- 4 Open-market buy President & CEO bought 372,000 shares at $0.67 ($250,282)
- 4 Open-market buy COO/CFO bought 100,000 shares at $0.59 ($59,110)
- 4 Open-market buy Chief Commercial Officer bought 25,000 shares at $0.60 ($15,050)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, Tech Ops and Admin sold 6,430 shares at $1.16 ($7,430)
- 4 Open-market sale COO/CFO sold 6,430 shares at $1.16 ($7,431)
Page 3 of 12 · 228 filings